ÂÜÀòÂÒÂ×

Jennifer Simpson is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. As President and CEO of Panbela Therapeutics since July 2020, Jennifer also serves as a board member for CytRx Corporation and Eagle Pharmaceuticals, Inc. Notably, Jennifer held various leadership roles at Delcath Systems, Inc. from March 2012 to June 2020, including President and CEO. Prior positions include EVP of Global Marketing at ImClone Systems and roles at Ortho Biotech and Tibotec Therapeutics. Jennifer holds a PhD in Epidemiology from the University of Pittsburgh, an MSN as a Nurse Practitioner from the University of Rochester, and a BSN in Nursing from the University at Buffalo, complemented by additional education from the American Management Association.